Tax & FinanceNational-Nov 20, 2026

DEA Faces Second Lawsuit From More Medical Marijuana Businesses That Say Rescheduling Rules Could Upend State Markets

Key Takeaway

A second group of medical cannabis businesses are suing the Drug Enforcement Administration (DEA) over restrictions the agency is placing on marijuana businesses in conjunction with the Trump administration's federal rescheduling move that industry observers and regulators believe could upend state-licensed markets. The latest challenge comes from four vertically integrated medical cannabis companies that say the

What This Means for Cannabis Businesses

Tax developments like this directly impact the bottom line for every cannabis operator. With Section 280E creating effective tax rates above 70% for many businesses, any shift in federal tax policy - whether through rescheduling, court rulings, or IRS guidance - can mean the difference between profitability and closure. Cannabis business owners should work closely with a specialized CPA to understand how these changes affect their specific situation.

This analysis is based on reporting by Marijuana Moment. Read the original article. CannaBizGuide provides original commentary and analysis - this is not legal or tax advice.